Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. It is not yet known which regimen of combination chemotherapy is
most effective for non-Hodgkin's lymphoma.
PURPOSE: This randomized phase III trial is studying two regimens of combination chemotherapy
and comparing how well they work in treating patients with aggressive non-Hodgkin's lymphoma.